Covered recipient · General Payments record
JAMES WON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$1,151.45
- Reported across 34 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $632.98 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GE HEALTHCARE | $175.45 | 7 |
| CATALYST PHARMACEUTICALS, INC. | $166.99 | 1 |
| Amgen Inc. | $128.47 | 4 |
| ANI Pharmaceuticals, Inc. | $105.66 | 4 |
| Averitas Pharma Inc. | $29.03 | 1 |
| ABBVIE INC. | $27.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.38 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204781324 | CMS |
| Amgen Inc. | $33.00 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228302887 | CMS |
| Amgen Inc. | $31.36 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228302881 | CMS |
| Amgen Inc. | $32.10 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228302883 | CMS |
| Amgen Inc. | $32.01 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228302885 | CMS |
| ANI Pharmaceuticals, Inc. | $26.13 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248630827 | CMS |
| ANI Pharmaceuticals, Inc. | $26.13 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248632319 | CMS |
| ANI Pharmaceuticals, Inc. | $26.89 | 10/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248612905 | CMS |
| ANI Pharmaceuticals, Inc. | $26.51 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248661935 | CMS |
| Averitas Pharma Inc. | $29.03 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248557749 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $166.99 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253218266 | CMS |
| GE HEALTHCARE | $25.55 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244286692 | CMS |
| GE HEALTHCARE | $25.75 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244294533 | CMS |
| GE HEALTHCARE | $24.50 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244290867 | CMS |
| GE HEALTHCARE | $25.10 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244288458 | CMS |
| GE HEALTHCARE | $25.19 | 06/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244285968 | CMS |
| GE HEALTHCARE | $25.08 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244289812 | CMS |
| GE HEALTHCARE | $24.28 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244289204 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.